Imipenem+Cilastatin
Imipenem+Cilastatin

Imipenem+Cilastatin

Zone 1B - Beauséjour: Gram Negative

% of Isolates Susceptible

100% n = 17
99% n = 3377
99% n = 105
98% n = 399
93% n = 55

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

86% n = 73

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

83% n = 238
44% n = 12

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information

28% n = 36

Resistance may develop during therapy if treated with cephalosporins or beta-lactam/beta-lactamase inhibitors, even if susceptible in vitro - see additional information